Therapeutic Drug Monitoring for Busulfan IV Dosing
THE CURRENT LANDSCAPE Intravenous (IV) Busulfan is an alkylating drug routinely used in conditioning regimens before allogenic haemopoietic cell transplantation...
Making A Difference Through Optimizing Cyclosporine Treatment With DoseMe
THE CUSTOMER Maribor University Medical Centre is one of the largest medical institutions in Slovenia. It is a public health...
Improving vancomycin dosing by shifting to AUC
DoseMe Crunch is built on the same algorithms that underpin DoseMeRx to determine if the current clinical approach of...
A New Approach to TDM of Tobramycin in CF
In this case review series by The Dosing Institute, DoseMe - a precision dosing software platform - is shown to...
HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.